Estudios morfologicos de los cristales de hidroxiapatita tratados con pamidronato disodico

Medicina

Volumn 57, Issue SUPPL. 1, 1997, Pages 10-16

  Hein, Lidia E ^a   Grassi, Reynaldo L ^a,b   Roldan, Emili J A ^c   Gregori, Daniel ^b   Varela, Maria E ^a   Piccinni, Enrique P ^c  

^a Universidad Provincial del Sudoeste   (Argentina)

^b UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^c Gador SA   (Argentina)

Author keywords

Cristalograf a; Hidroxiapatita; Pamidronato

Indexed keywords

HYDROXYAPATITE; PAMIDRONIC ACID; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CRYSTAL STRUCTURE; INFRARED SPECTROMETRY; NONHUMAN; OSTEOPOROSIS; RABBIT; RAMAN SPECTROMETRY; ANIMAL; CHEMISTRY; CRYSTALLIZATION; TIME;

ANIMALS; BIOCOMPATIBLE MATERIALS; CRYSTALLIZATION; DIPHOSPHONATES; DURAPATITE; RABBITS; TIME FACTORS;

EID: 0031325199     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ferretti JL, Cointry G, Capozza R, Montuori E, Roldán E, Pérez Lloret A. Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD) on femur diaphysis and cortical bone tissue in rats. Bone Miner 1990; 11: 111-22.
2. Ferretti JL, Delgado CJ, Capozza RF, et al. Protective effects of disodium etidronate and pamidronate against the biochemical repercussion of betamethasone-induced osteopenia in growing rat femurs. Bone Miner 1993; 20: 265-76.
3. Cointry GR, Mondelo N, Zanchetta JR, Montuori E, Ferretti JL. Intravenous olpadronate restores ovariectomy-affected bone strength. A mechanical, densitometric and tomographic (pQCT) study. Bone 1995; 17 (supl): 373S-378S.
4. Riggs BL, Hodgson SF, O'Fallon, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802-9.
5. Guañabens N, Peris P, Monegal F, Pons F, Collado A, Muñoz-Gómez J. Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis. Calcif Tissue Int 1994; 54: 431-4.
6. Thomas T, Vico L, Skerry TM, et al. Architectural modifications and cellular response during disuserelated bone loss in calcaneus of the sheep. Am J Physiol 1996; 80: 198-202.
7. Chigire M. Mechanical optimization of bone. Med Hypoth 1996; 46: 327-30.
8. Rígoli NS, Keselman HR, L'Argentiere PC. Preparación de hidroxiapatitas y su uso en las hidrólisis de clorobenceno. Rev Fac Ing Quim (Santa Fe) 1978/ 9; 44: 282-9.
9. Scherrer P, Gottinger N. Crystallite size determinations from line broadening and spotty patterns. In: Handbook of X-rays, (ed) EF Kaelbe, 1967; 17-8.
10. van Beek E, Hoekstra M, van de Ruit M, Lowik C, Papapoulos E. Structural requirements for bisphosphonate actions in vitro. J Bone Miner Res 1994; 9: 1875-82.
11. Ravaglioli A, Krajewski A, Celotti GC, et al. Mineral evolution of bone. Biomaterials 1996; 17: 617-22.
12. Tenenbaum HC, Torontali M, Sukhu B. Effects of bisphosphonates and inorganic pyrophosphates on osteogenesis in vitro. Bone 1992; 13: 249-55.
13. Fratzl P, Schreiber S, Roschger P, et al. Effects of sodium fluoride and alendronate on the bone mineral in minipigs: A small-angle Y-Ray scattering and backscattered electron imaging study. J Bone Miner Res 1996; 11: 248-53.